Cargando…

Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlook

Immunotherapy (IO) has revolutionized the therapy landscape of non-small cell lung cancer (NSCLC), significantly prolonging the overall survival (OS) of advanced stage patients. Over the recent years IO therapy has been broadly integrated into the first-line setting of non-oncogene driven NSCLC, eit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horvath, Lena, Thienpont, Bernard, Zhao, Liyun, Wolf, Dominik, Pircher, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488475/ https://www.ncbi.nlm.nih.gov/pubmed/32917214 http://dx.doi.org/10.1186/s12943-020-01260-z

Ejemplares similares

ASCO 2020 non-small lung cancer (NSCLC) personal highlights
por: Horvath, Lena, et al.
Publicado: (2021)

Characterization of the tumor microenvironment by single-cell RNA sequencing in non-small cell lung cancer treated with neo-adjuvant immunotherapy
por: Nagl, Laurenz, et al.
Publicado: (2023)

High indoleamine-2,3-dioxygenase 1 (IDO) activity is linked to primary resistance to immunotherapy in non-small cell lung cancer (NSCLC)
por: Kocher, Florian, et al.
Publicado: (2021)

Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment – New Findings and Future Perspectives
por: Nagl, Laurenz, et al.
Publicado: (2020)

The future outlook on allergen immunotherapy in children: 2018 and beyond
por: Arasi, Stefania, et al.
Publicado: (2018)

The Role of Anti-angiogenesis in the Treatment Landscape of Non-small Cell Lung Cancer – New Combinational Approaches and Strategies of Neovessel Inhibition
por: Daum, Sophia, et al.
Publicado: (2021)

Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects
por: Boesch, Maximilian, et al.
Publicado: (2022)

The Future Outlook
Publicado: (1919)

The Outlook for the Future
Publicado: (1903)

Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
por: Chiu, Li-Chung, et al.
Publicado: (2021)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
por: Brahmer, Julie R., et al.
Publicado: (2018)

Present Considerations and Future Outlook
Publicado: (1921)

Large Improvements and Future Outlook
Publicado: (1920)

Broiler genetics and the future outlook
por: Siegel, Paul B.
Publicado: (2023)

Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
por: Moya-Horno, Irene, et al.
Publicado: (2018)

Insights Gained and Future Outlook From scRNAseq Studies in Autoimmune Rheumatic Diseases
por: Zheng, Zihan, et al.
Publicado: (2022)

Allergen immunotherapy for food allergy: Evidence and outlook
por: Muraro, Antonella, et al.
Publicado: (2022)

Liquid biopsy in non-small cell lung cancer—current status and future outlook—a narrative review
por: Smolle, Elisabeth, et al.
Publicado: (2021)

Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality
por: Pircher, Andreas, et al.
Publicado: (2017)

Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives
por: Lazzari, Chiara, et al.
Publicado: (2023)

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)
por: Assi, Hazem I., et al.
Publicado: (2023)

ASCO 2018 NSCLC highlights—combination therapy is key
por: Gamerith, Gabriele, et al.
Publicado: (2018)

PLANT RESOURCES FOR AYURVEDA: AN OUTLOOK FOR THE FUTURE
por: Sivarajan, V. V., et al.
Publicado: (1983)

Helium: Current Status And Future Outlook
por: Fowler, W B
Publicado: (1990)

The Pay of the Nurse. VIII.—The Outlook for the Future
Publicado: (1921)

Biocosmetics: technological advances and future outlook
por: Goyal, Nishu, et al.
Publicado: (2021)

Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
por: Fan, Jia-qiao, et al.
Publicado: (2020)

Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance
por: Pu, Xingxiang, et al.
Publicado: (2018)

Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment
por: Botticelli, Andrea, et al.
Publicado: (2020)

Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)
por: Martinez-Marti, A, et al.
Publicado: (2017)

A new approach to overcoming resistance to immunotherapy: nanotechnology
por: Shao, Jiangbo, et al.
Publicado: (2023)

Immunotherapy in the First-Line Treatment of NSCLC: Current Status and Future Directions in China
por: Xiong, Anwen, et al.
Publicado: (2021)

Immunotherapy Combined with Metronomic Dosing: An Effective Approach for the Treatment of NSCLC
por: Skavatsou, Eleni, et al.
Publicado: (2021)

Adaptive designs: current status, future outlook
por: Grieve, Andy
Publicado: (2011)

Personnel monitoring at CERN: experience and future outlook
por: Höfert, M
Publicado: (1985)

Current Status and Future Outlook for Nonwovens in Japan
por: Yaida, Osamu
Publicado: (2016)

Education for future biobankers - The state-of-the-art and outlook
por: Kinkorová, Judita
Publicado: (2021)

PSMA Theranostics: Current Landscape and Future Outlook
por: Zhang, Hanbo, et al.
Publicado: (2021)

Synthesis of Nanogels: Current Trends and Future Outlook
por: Mauri, Emanuele, et al.
Publicado: (2021)

Antithrombin Therapy: Current State and Future Outlook
por: Rodgers, George M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d3gu5f3n56tek1bmu18sbkf28h